Genzyme receives positive CHMP opinion in the European Union for once-daily, oral AUBAGIO® to treat relapsing-remitting multiple sclerosis
Genzyme, 22 Mar 2013
Accessed on 25 Mar 2013 from http://news.genzyme.com/press-release/genzyme-receives-positive-chmp-opinion-european-union-once-daily-oral-aubagio-treat-re.